Effect of Remimazolam Use During Perioperative Period on Brain Waves and Postoperative Cognitive Function

Benzodiazepine Clinical Trial

Official title:
Effect of Remimazolam Use During Perioperative Period on Brain Waves and Postoperative Cognitive Function

Status Completed

Clinical Trial Summary

Benzodiazepine sedative hypnotics are commonly used intravenous anesthetics in clinical practice. Remimazolam is a new benzodiazepine with the characteristics of rapid onset, short maintenance and recovery time, no accumulation, metabolism independent of liver and kidney function, and no serious side effects, which has a good prospect for clinical application. Now we will study the effects of remimazolam on EEG and postoperative cognitive function ，in order to further understand the clinical application of remimazolam.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Benzodiazepine

Clinical Trial Details

NCT number	NCT04601350
Study type	Interventional
Source	Yangzhou University
Contact
Status	Completed
Phase	N/A
Start date	November 1, 2020
Completion date	June 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01431326` - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Completed	`NCT04861337` - Remimazolam and Postoperative Nausea and Vomiting in High-risk Patients	Phase 4
Recruiting	`NCT06197243` - Augmenting Benzodiazepine Receptor Agonist Deprescribing With Acupuncture and Yoga Among Older Adults	N/A